drugset / Trial / NCT05183347
A Study in Healthy Japanese Men to Test How Well Different Doses of BI 1291583 Are Tolerated
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 1291583 in healthy male Japanese subjects following oral administration of single rising doses and multiple doses.
Timeline
- Start
- 2022-02-04
- Primary completion
- 2022-07-27
- Completion
- 2022-07-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1291583 | Unknown | — | Oral |
Indications
No indication recorded.